activity
20232026
most citedBioNeMo Framework: a modular, high-performance library for AI model development in drug discovery

11 citations · 28 across the 12 of their papers we have counts for

collaborators

12 papers

cs.LG2026★ 1 cited

Scaling Atomistic Protein Binder Design with Generative Pretraining and Test-Time Compute

Kieran Didi, Zuobai Zhang, Guoqing Zhou +11

Protein interaction modeling is central to protein design, which has been transformed by machine learning with applications in drug discovery and beyond. In this landscape, structu…

q-bio.BM2025

Consistent Synthetic Sequences Unlock Structural Diversity in Fully Atomistic De Novo Protein Design

Danny Reidenbach, Zhonglin Cao, Zuobai Zhang +8

High-quality training datasets are crucial for the development of effective protein design models, but existing synthetic datasets often include unfavorable sequence-structure pair…

cs.LG2025★ 1 cited

Exploring Synthesizable Chemical Space with Iterative Pathway Refinements

Seul Lee, Karsten Kreis, Srimukh Prasad Veccham +5

A well-known pitfall of molecular generative models is that they are not guaranteed to generate synthesizable molecules. Existing solutions for this problem often struggle to effec…

cs.LG2025

Efficient Molecular Conformer Generation with SO(3)-Averaged Flow Matching and Reflow

Zhonglin Cao, Mario Geiger, Allan dos Santos Costa +6

Fast and accurate generation of molecular conformers is desired for downstream computational chemistry and drug discovery tasks. Currently, training and sampling state-of-the-art d…

cs.LG2025★ 3 cited

La-Proteina: Atomistic Protein Generation via Partially Latent Flow Matching

Tomas Geffner, Kieran Didi, Zhonglin Cao +6

Recently, many generative models for de novo protein structure design have emerged. Yet, only few tackle the difficult task of directly generating fully atomistic structures jointl…

cs.LG2025

Applications of Modular Co-Design for De Novo 3D Molecule Generation

Danny Reidenbach, Filipp Nikitin, Olexandr Isayev +1

De novo 3D molecule generation is a pivotal task in drug discovery. However, many recent geometric generative models struggle to produce high-quality 3D structures, even if they ma…

cs.LG2025★ 3 cited

Proteina: Scaling Flow-based Protein Structure Generative Models

Tomas Geffner, Kieran Didi, Zuobai Zhang +8

Recently, diffusion- and flow-based generative models of protein structures have emerged as a powerful tool for de novo protein design. Here, we develop Proteina, a new large-scale…

cs.LG2025★ 4 cited

GenMol: A Drug Discovery Generalist with Discrete Diffusion

Seul Lee, Karsten Kreis, Srimukh Prasad Veccham +6

Drug discovery is a complex process that involves multiple stages and tasks. However, existing molecular generative models can only tackle some of these tasks. We present Generalis…

cs.LG2024★ 1 cited

Molecule Generation with Fragment Retrieval Augmentation

Seul Lee, Karsten Kreis, Srimukh Prasad Veccham +5

Fragment-based drug discovery, in which molecular fragments are assembled into new molecules with desirable biochemical properties, has achieved great success. However, many fragme…

cs.LG2024★ 11 cited

BioNeMo Framework: a modular, high-performance library for AI model development in drug discovery

Peter St. John, Dejun Lin, Polina Binder +89

Artificial Intelligence models encoding biology and chemistry are opening new routes to high-throughput and high-quality in-silico drug development. However, their training increas…

cs.LG2024★ 3 cited

General Binding Affinity Guidance for Diffusion Models in Structure-Based Drug Design

Yue Jian, Curtis Wu, Danny Reidenbach +1

Structure-based drug design (SBDD) aims to generate ligands that bind strongly and specifically to target protein pockets. Recent diffusion models have advanced SBDD by capturing t…

cs.LG2023★ 1 cited

CoarsenConf: Equivariant Coarsening with Aggregated Attention for Molecular Conformer Generation

Danny Reidenbach, Aditi S. Krishnapriyan

Molecular conformer generation (MCG) is an important task in cheminformatics and drug discovery. The ability to efficiently generate low-energy 3D structures can avoid expensive qu…